Cart
sales@molnova.com
AM-1235
CAS No. 335161-27-8
AM-1235( —— )
Catalog No. M34496 CAS No. 335161-27-8
AM-1235 is a potent and selective cannabinoid receptor CB1 agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 787 | In Stock |
|
| 10MG | 1074 | In Stock |
|
| 25MG | 1511 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | 2325 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAM-1235
-
NoteResearch use only, not for human use.
-
Brief DescriptionAM-1235 is a potent and selective cannabinoid receptor CB1 agonist.
-
DescriptionAM-1235 is a potent and selective cannabinoid receptor CB1 agonist.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCannabinoid Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number335161-27-8
-
Formula Weight404.43
-
Molecular FormulaC24H21FN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(C=1C=2C(N(CCCCCF)C1)=CC(N(=O)=O)=CC2)C=3C4=C(C=CC3)C=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Alismoxide
Alismoxide has anti-inflammatory effects.
-
CB1 antagonist 2
CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.
-
CB2R/FAAH?modulator-...
CB2R/FAAH modulator-2 (compound 26) is a dual modulator targeting CB2R and FAAH, acting as a CB2R agonist (Ki = 10.8 nM) and FAAH inhibitor (IC50 = 6.2 μM), with a Ki value of 152.9 nM for CB1R.
